contents

america
 

Only 5 Weeks Until “Investment In Innovation West” Conference

Medtech Insight, a division of Windhover Conferences and a leading provider of business information for the medical device industry, has announced that more than 40 early- to late-stage companies are confirmed to date to present at their upcoming "Investment In Innovation (In3) West" conference, being held March 2-4, 2009 at The Palazzo Resort ● Hotel ● Casino in Las Vegas, NV. Nearly 50 companies will present on the In3 West stage in total. It is a do-not-miss event for those looking to partner, invest and network with the most promising young medical technology companies on course to impact the worldwide med device market.

Join teams that have already registered from companies like Abbott Laboratories, Ethicon Endo-Surgery, Inc., Frazier Healthcare Ventures, Versant Ventures, C.R. Bard, Inc., Stryker Instruments, Baxter Healthcare Corporation, Bristol-Myers-Squibb, Genzyme Corporation, Medtronic and more! Secure your spot today for the Leading Medical Device Strategic Partnering and Investment Event now before the event sells out.

The two-day In3 West event – the company's 33rd In3 conference –begins the evening of March 2nd and will showcase nearly 50 highly promising start-up med device companies from around the world presenting to an audience of senior business development and investment executives from the leading medical technology and healthcare investment firms worldwide, for purposes of raising funding or forming strategic partnerships. Presenting companies to date (with many presenting at an In3 event for the first time) include Athena Feminine Technologies, Bioheart, Inc., BioLineRx, Ltd., Celerus Diagnostics, Inc., CVAC Systems, Inc., Disc Motion Technologies, Discovery Technology International, LLP, e-Zassi, LLC, Freedom Meditech Inc., Genesis Medical Interventional, Inc., Healionics Corporation, Intellewave, Kuros Biosurgery, AG, LifeWave, Inc., LineaGen, Inc., MiCardia Corporation, MicroTransponder Inc., Nanospectra Biosciences, Inc., NeoMend, Inc., Nerites Corporation, NuLens, Ltd., PEAK Surgical, pico-tesla Magnetic Therapies, LLC, Polymedix, Inc., Prizm Medical Inc., Sequoia Medtech, Sherlock-NMD, Sleepvirtual, Soft Tissue Regeneration, superDimension Inc., ThromboVision, Inc., TrueVision Systems, Inc., Urovalve, Vertos Medical Inc., VG Innovations, LLC, Victhom Human Bionics, Inc., ViOptix, Inc. and Zassi Medical Evolutions, LLC, among many others being added to the program regularly.

The single-track In3 West format will include focused 10-minute presentations by a senior executive from each presenting company to our full audience; each followed immediately by one-on-one meetings with interested parties in private breakout rooms. The event will also feature an informative panel discussion entitled "What are the Hot Deals Now and in the Future, " with panelists to include David Cassak, Managing Partner, Windhover Information, Tom Salemi, Staff Writer, INVIVO, STARTUP, Jeani Delagardelle, Managing Director, New Leaf Venture Partners, Kevin Wasserstein, Managing Director, Versant Ventures, Annette Campbell-White, Senior Managing Member, MedVenture Associates, Trevor Moody, General Partner, Frazier Healthcare Ventures. A presenting company product exhibition and networking reception will take place on Tuesday evening, March 3. A second interactive panel discussion will be held on Wednesday morning, March 4 entitled "Financing Device Companies During Tough Economic Times: How I Learned to Love a Down Round, " with panelists to include David Cassak, Managing Partner, Windhover Information, Stephen Levin, Executive Editor, FDC Windhover, Alan Kaganov, Partner, U.S. Venture Partners, Andrew Weiss, President and CEO, CoAxia and Dan Sullivan, CEO, and superDimension, Inc. In3 East sponsors include AdvaMed, MDMA, Medmarc and The Hartford, The MedTech Group, Ronald Trahan Associates, Germany Trade and Invest, Synectic Inc., and FDC Reports' The Gray Sheet.

Medtech Insight and its parent company Windhover Conferences, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1400 emerging medical technology company presenters and over 7500 attendees have participated at In3 events over the past 8 years.



write your comments about the article :: © 2009 Exhibition News :: home page